Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFenner PLC Regulatory News (FENR)

  • There is currently no data for FENR

Interim Management Statement

19 Jul 2010 07:00

RNS Number : 4946P
Fenner PLC
19 July 2010
 



 

19 July 2010

 

Fenner PLC ("Fenner")

 

INTERIM MANAGEMENT STATEMENT

 

Fenner PLC today issues an update of events since its Half Year results which were released on 28 April 2010.

 

Market Overview and Operations

 

Trading across the whole group has continued the strong growth experienced in our second quarter with revenue and underlying operating profit (at constant exchange rates) in the third quarter of the financial year well ahead of the comparable period last year.

 

Trading in the Advanced Engineered Products division has exceeded our expectations, with growth from the underlying recovery in industrial markets, particularly the US, supplemented by a re-stocking of supply chains in certain operations. Our seals business has benefitted from good levels of demand from the oil and gas sector and improved order intake in the general hydraulic sector. Despite the continuing wider economic uncertainty, our other businesses in the division, focused on niche areas of expertise, have made solid progress and we are seeing new opportunities in both established and new territories. Our business development programme in our technical weaving business, which includes Secant Medical, has enhanced opportunities for generating new revenue streams organically and our acquisition in July 2010 of MRI Manufacturing and Research, Inc. ("MRI") strengthens further our presence in supplying the medical device market.

 

The Conveyor Belting division, which was largely unaffected by the economic downturn, has continued to perform well. The benefits from recent capital investments are increasingly generating operational efficiencies. We continue to pursue opportunities for acquisitive growth in our service businesses.

 

Financial Position

 

In April, Fenner raised gross proceeds of approximately £36.3 million through the placing of 17,302,233 new ordinary shares to help provide the Group with the financial flexibility to continue to finance strategic acquisitions that will further enhance our business. The first of these acquisitions, MRI, was announced earlier this month.

 

Operating cash flow continues to be strong, benefiting from healthy trading and the completion of major internal capital projects last year. Borrowings remain in line with expectations.

 

Outlook

 

With over 75% of group revenues generated in economies outside the UK and Continental Europe, Fenner's business is geographically well-diversified. Order flows continue to be encouraging and with trading comfortably meeting our expectations, we are confident in both the short and longer term outlook for the business.

 

 

Certain statements contained in this document constitute forward-looking statements. Such forward-looking statements involve risks, uncertainties and other factors which may cause the actual results, performance or achievements of Fenner, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such statements.

 

- ends -

 

 

For further information please contact:

 

Fenner PLC

01482 626501

Mark Abrahams, Chief Executive

Richard Perry, Finance Director

Weber Shandwick Financial

020 7067 0700

Nick Oborne / Stephanie Badjonat

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGUCPMUPUGWQ
Date   Source Headline
21st Mar 201811:53 amRNSForm 8.3 - Fenner Plc
21st Mar 201810:20 amRNSForm 8.3 - Fenner plc
21st Mar 20189:51 amRNSForm 8.5 (EPT/NON-RI) - Fenner plc
21st Mar 20189:43 amRNSForm 8.5 (EPT/RI) - Fenner plc
21st Mar 20189:42 amRNSForm 8.5 (EPT/RI) - Fenner plc
21st Mar 20189:20 amRNSForm 8.3 - Fenner Plc
21st Mar 20189:20 amPRNForm 8.3 - Fenner PLC
21st Mar 20187:37 amRNSForm 8.5 (EPT/NON-RI) Fenner plc
21st Mar 20187:00 amRNSForm 8.3 - [Fenner PLC]
20th Mar 20183:21 pmRNSForm 8.3 - Fenner Plc
20th Mar 20183:10 pmRNSForm 8.3 - Fenner Plc
20th Mar 20183:09 pmRNSForm 8.3 - Fenner plc
20th Mar 20181:39 pmRNSForm 8.3 - Fenner Plc
20th Mar 20181:15 pmBUSForm 8.3 - Fenner plc
20th Mar 201811:56 amPRNForm 8.3 - Fenner Plc
19th Mar 20185:14 pmRNSOffer for Fenner plc
5th Mar 20187:00 amRNSAcquisition
1st Mar 201810:00 amRNSBlock listing Interim Review
19th Jan 20183:36 pmRNSDirector/PDMR Shareholding
12th Jan 201811:40 amRNSResult of AGM
11th Jan 20187:00 amRNSAGM Trading Update
20th Dec 20177:00 amRNSDirectorate Change
12th Dec 201711:27 amRNSDocuments available for viewing/Notice of AGM
15th Nov 20177:00 amRNSFinal Results
5th Oct 201712:35 pmRNSHolding(s) in Company
5th Sep 20173:14 pmRNSHolding(s) in Company
1st Sep 20179:41 amRNSBlock listing Interim Review
29th Aug 20177:00 amRNSAcquisition
22nd Aug 201711:26 amRNSHolding(s) in Company
17th Aug 20179:55 amRNSHolding(s) in Company
14th Aug 201710:12 amRNSHolding(s) in Company
25th Jul 20177:00 amRNSSupply Agreement & Disposal of S.A. Sales Branches
21st Jul 20177:00 amRNSAppointment of Joint Corporate Broker
13th Jul 201710:02 amRNSDirector/PDMR Shareholding - REPLACEMENT
13th Jul 20179:20 amRNSDirector/PDMR Shareholding
12th Jul 20173:06 pmRNSDirector/PDMR Shareholding
7th Jul 20177:00 amRNSTrading Update
3rd Jul 201710:47 amRNSDirector Declaration
20th Jun 201710:12 amRNSHolding(s) in Company
15th Jun 201710:13 amRNSHolding(s) in Company
2nd Jun 201712:03 pmRNSHolding(s) in Company
19th Apr 20177:00 amRNSHalf-year Report
18th Apr 201710:51 amRNSHolding(s) in Company
7th Mar 20173:56 pmRNSHolding(s) in Company
1st Mar 201711:16 amRNSBlock listing Interim Review
23rd Feb 20179:20 amRNSHolding(s) in Company
15th Feb 20179:38 amRNSDisposal
7th Feb 201712:35 pmRNSHolding(s) in Company
7th Feb 201710:33 amRNSHolding(s) in Company
27th Jan 20179:12 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.